Camberley, United Kingdom

William Dawson


Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Camberley, EN (1977)
  • Camberley, GB (1978 - 1983)

Company Filing History:


Years Active: 1977-1983

Loading Chart...
5 patents (USPTO):Explore Patents

Title: William Dawson: Innovator in Medical Treatments

Introduction

William Dawson is a notable inventor based in Camberley, GB. He has made significant contributions to the field of medical treatments, particularly in the area of hypersensitivity diseases. With a total of 5 patents to his name, Dawson's work has the potential to impact many lives.

Latest Patents

Dawson's latest patents include a method of treating hypersensitivity disease with benzoxazole derivatives. This invention relates to a method for the prophylactic or therapeutic treatment of immediate hypersensitivity diseases. It involves administering a specific compound to mammals, including humans, which has shown promise in alleviating symptoms. Another notable patent involves cyclopentone propanoic acid compounds, which are useful as anti-thrombotic agents. These compounds are derivatives of propanoic acid and have potential applications in treating thrombotic conditions.

Career Highlights

William Dawson is currently associated with Lilly Industries, Inc., where he continues to innovate and develop new medical treatments. His work has garnered attention in the medical community, and he is recognized for his contributions to pharmaceutical advancements.

Collaborations

Dawson has collaborated with several professionals in his field, including Michael John Foulis and Norman James Gutteridge. These collaborations have likely enhanced the scope and impact of his inventions.

Conclusion

William Dawson is a distinguished inventor whose work in medical treatments has the potential to make a significant difference in healthcare. His innovative patents reflect his commitment to improving the lives of those affected by hypersensitivity diseases and thrombotic conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…